These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24973797)

  • 1. Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia.
    Cheah AL; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC
    BMC Infect Dis; 2014 Jun; 14():353. PubMed ID: 24973797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia.
    Peel T; Cheng AC; Spelman T; Huysmans M; Spelman D
    Clin Microbiol Infect; 2012 Apr; 18(4):388-94. PubMed ID: 21848977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization.
    Cheah AL; Spelman T; Liew D; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC
    Clin Microbiol Infect; 2013 Apr; 19(4):E181-9. PubMed ID: 23398607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation.
    Vydra J; Shanley RM; George I; Ustun C; Smith AR; Weisdorf DJ; Young JA
    Clin Infect Dis; 2012 Sep; 55(6):764-70. PubMed ID: 22693346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, treatment and outcomes of bloodstream infection due to vancomycin-resistant enterococci in cancer patients in a vanB endemic setting.
    Xie O; Slavin MA; Teh BW; Bajel A; Douglas AP; Worth LJ
    BMC Infect Dis; 2020 Mar; 20(1):228. PubMed ID: 32188401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of vanB vancomycin-resistant enterococcal bacteraemia analysed as a time-varying covariate on length of hospital stay.
    Cheah AL; Spelman T; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC
    Epidemiol Infect; 2014 Dec; 142(12):2667-71. PubMed ID: 25372228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Australian Group on Antimicrobial Resistance (AGAR) Australian Enterococcal Sepsis Outcome Programme (AESOP) Annual Report 2017.
    Coombs GW; Daley DA; Lee YT; Pang S
    Commun Dis Intell (2018); 2019 Sep; 43():. PubMed ID: 31522664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical manifestations, characteristics, and outcome of infections caused by vancomycin-resistant enterococci at a tertiary care center in Lebanon: A case-case-control study.
    Abi Frem J; Ghanem M; Doumat G; Kanafani ZA
    J Infect Public Health; 2023 May; 16(5):741-745. PubMed ID: 36958169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology of vancomycin-resistant enterococcal bacteraemia: results from the Canadian Nosocomial Infection Surveillance Program, 1999-2009.
    McCracken M; Wong A; Mitchell R; Gravel D; Conly J; Embil J; Johnston L; Matlow A; Ormiston D; Simor AE; Smith S; Du T; Hizon R; Mulvey MR;
    J Antimicrob Chemother; 2013 Jul; 68(7):1505-9. PubMed ID: 23524466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of exposure to multiple antibiotics is associated with increased risk of VRE bacteraemia: a nested case-control study.
    Gouliouris T; Warne B; Cartwright EJP; Bedford L; Weerasuriya CK; Raven KE; Brown NM; Török ME; Limmathurotsakul D; Peacock SJ
    J Antimicrob Chemother; 2018 Jun; 73(6):1692-1699. PubMed ID: 29548009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin-resistant enterococcus bacteraemia in an endemic region: clinical features and genomic analysis: a 12-year cohort.
    Abu-Lybdeh O; Murik O; Oster Y; Assous MV; Mann T; Zeevi DA; Benenson S; Wiener-Well Y
    J Hosp Infect; 2022 Mar; 121():105-113. PubMed ID: 34896188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of vancomycin-variable Enterococcus faecium (VVE) among vanA-positive sterile site isolates and patient factors associated with VVE bacteremia.
    Kohler P; Eshaghi A; Kim HC; Plevneshi A; Green K; Willey BM; McGeer A; Patel SN;
    PLoS One; 2018; 13(3):e0193926. PubMed ID: 29566004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology of vancomycin resistant enterococci in a tertiary care hospital in Saudi Arabia.
    Somily AM; Al-Mohizea MM; Absar MM; Fatani AJ; Ridha AM; Al-Ahdal MN; Senok AC; Al-Qahtani AA
    Microb Pathog; 2016 Aug; 97():79-83. PubMed ID: 27247096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.
    Bhavnani SM; Drake JA; Forrest A; Deinhart JA; Jones RN; Biedenbach DJ; Ballow CH
    Diagn Microbiol Infect Dis; 2000 Mar; 36(3):145-58. PubMed ID: 10729656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species, antibiotic susceptibility profiles and van gene frequencies among enterococci isolated from patients at Mulago National Referral Hospital in Kampala, Uganda.
    Kateete DP; Edolu M; Kigozi E; Kisukye J; Baluku H; Mwiine FN; Najjuka CF
    BMC Infect Dis; 2019 May; 19(1):486. PubMed ID: 31151413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thirty years of VRE in Germany - "expect the unexpected": The view from the National Reference Centre for Staphylococci and Enterococci.
    Werner G; Neumann B; Weber RE; Kresken M; Wendt C; Bender JK;
    Drug Resist Updat; 2020 Dec; 53():100732. PubMed ID: 33189998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Enterococcal Bacteremia in Liver Transplant Recipients.
    Kim YJ; Jun YH; Choi HJ; You YK; Kim DG; Choi JY; Yoon SK; Kim SI
    Transplant Proc; 2019 Oct; 51(8):2766-2770. PubMed ID: 31493916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients.
    Papadimitriou-Olivgeris M; Drougka E; Fligou F; Kolonitsiou F; Liakopoulos A; Dodou V; Anastassiou ED; Petinaki E; Marangos M; Filos KS; Spiliopoulou I
    Infection; 2014 Dec; 42(6):1013-22. PubMed ID: 25143193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. vanA and vanB incorporate into an endemic ampicillin-resistant vancomycin-sensitive Enterococcus faecium strain: effect on interpretation of clonality.
    Suppola JP; Kolho E; Salmenlinna S; Tarkka E; Vuopio-Varkila J; Vaara M
    J Clin Microbiol; 1999 Dec; 37(12):3934-9. PubMed ID: 10565910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing trend in enterococcal bacteraemia and vancomycin resistance in a tertiary care hospital in Croatia, 2017-2021.
    Todorić Z; Majdandžić I; Keretić Kregar T; Herljević Z; Ćorić M; Lešin J; Kuliš T; Mareković I
    Infect Dis (Lond); 2023 Jan; 55(1):9-16. PubMed ID: 36240424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.